CD274 and neoplasm: Although the function and mechanism of release is debated, sPD-L1 could be alternative for clinical use, especially for patients without enough tumor tissue to test, which has been demonstrated by lots of previous studies.[21–23] However, data were insufficient to describe the changes in the PD-1/PD-L1 level during thoracic radiotherapy (TRT).